leisure time -WSS

leisure time

author：focus 2025-10-02 22:57:00 - browse：1

Each COVID-19 vaccine vial from various companies is placed on individual rectangular backgrounds. Pfizer-BioNTech is positioned in the middle on a purple block adorned with two glitter star stickers, Moderna is on the top right on a red block, Janssen is on the bottom right on a blue block, and AstraZeneca is on the left on a red block. — Illustration: Christine Kao/STAT; Photos: Getty

It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people and brought the world to its knees. A key factor in taming the pandemic was the creation of effective vaccines, which have saved millions of lives.

You’d think developing a successful vaccine would be an unmitigated win, from a financial perspective. And, indeed, for Pfizer and its partner BioNTech, as well as for Moderna — whose vaccines were the most widely used in the United States and much of the world — the revenues generated were absolutely staggering. But investors have shrugged at those sales as gains that will not be repeated.

Total sales of the Pfizer/BioNTech vaccine surpassed $80 billion, and more than 400 million doses of the shot and subsequent boosters have been administered in the U.S. alone. But the company’s stock price fell 32% over the past five years. Meanwhile, AstraZeneca, which told STAT it has not booked sales from its vaccine since last April and does not expect future sales, has seen its share price rise 64%. Merck, which saw its vaccine efforts fail twice, is up 56%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Google says AlphaFold 3 can map a vast universe of biomolecules

WSS

The kidney, in all its complexity, is captured in a new atlas

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Resistance to cancer drugs: A new genetic explanation

DOJ, FTC to increase scrutiny of all types of health care mergers

Researchers on aging grapple with how to calculate biological age

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

hotspot

leisure time

hotspot

Guidelines to prevent youth baseball injuries need more muscle

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

As demand for Covid shots wanes, Moderna seeks its next success

States increasingly look to regulate hospital facility fees

23andMe had bad news about my health. I wish a person had delivered it

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Cancer drug shortages should be causing more outrage

Stanford updates investigation of president’s past research

Cancer drug shortages should be causing more outrage

'Reaching a detente': STAT's Helen Branswell on covering Covid

knowledge

States increasingly look to regulate hospital facility fees

CDC wastewater surveillance dashboard to track bird flu hotspots

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

How dance can help health care workers heal from trauma

Telehealth startups turn to complex chronic diseases

explore

knowledge

hotspot

knowledge